Pancreatic Cancer Research

ResearcherDartmouth CollegeNo recent work listed

Arief Antonius Suriawinata

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-1595-4332; OpenAlex author ID A5001118529. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: 2 papers · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 9

  1. Graph Convolutional Neural Networks for Histologic Classification of Pancreatic Cancer. Co-author DOI 10.5858/arpa.2022-0035-oa↗
  2. Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: Histopathology, Cytopathology, and Molecular Pathology. Last author DOI 10.1016/j.ajpath.2018.10.004↗
  3. The genomic profile of pancreatic adenocarcinoma and its relationship to metastatic disease. Co-author DOI 10.1016/j.yexmp.2016.07.011↗
  4. Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and f… Co-author DOI 10.18632/oncotarget.7718↗
  5. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer. Co-author DOI 10.1016/j.cgh.2014.02.038↗
  6. The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. Co-author DOI 10.1097/mpa.0000000000000162↗
  7. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Co-author DOI 10.1016/j.cancergen.2013.05.020↗
  8. Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant therapy and pancreaticoduodenectomy. Co-author PMID 24147160↗
  9. Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. Co-author DOI 10.1093/annonc/mds109↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gregory J. Tsongalis · 7 shared papers, 2012–2016 · strength 0.28
  2. Saeed Hassanpour Ghady · 1 shared paper, 2023 · strength 0.24
  3. Weiyi Wu · 1 shared paper, 2023 · strength 0.24
  4. Stuart R. Gordon · 6 shared papers, 2012–2016 · strength 0.21
  5. Timothy B. Gardner · 5 shared papers, 2012–2016 · strength 0.17
  6. Bing Ren · 1 shared paper, 2019 · strength 0.16
  7. Richard J. Barth · 4 shared papers, 2012–2016 · strength 0.14
  8. J. Marc Pipas · 4 shared papers, 2012–2014 · strength 0.13
  9. Francine Blumental De Abreu · 2 shared papers, 2016 · strength 0.11
  10. Kerrington D. Smith · 3 shared papers, 2012–2016 · strength 0.10
  11. Bassem I. Zaki · 3 shared papers, 2012–2014 · strength 0.10
  12. Kirsten J. Pierce · 1 shared paper, 2016 · strength 0.07
  13. Xiulan Liu · 1 shared paper, 2016 · strength 0.07
  14. Craig R. Tomlinson · 1 shared paper, 2016 · strength 0.04
  15. Robert J. Allaway · 1 shared paper, 2016 · strength 0.04
  16. Minda A Gowarty · 1 shared paper, 2013 · strength 0.04
  17. Yue Xue · 1 shared paper, 2013 · strength 0.04
  18. Kabir Mody · 1 shared paper, 2014 · strength 0.04
  19. Anna E. Szafranska-Schwarzbach · 1 shared paper, 2014 · strength 0.03
  20. Shivakumar Vignesh · 1 shared paper, 2014 · strength 0.03
  21. Bernard F. Andruss · 1 shared paper, 2014 · strength 0.03
  22. Johanna B. Munding · 1 shared paper, 2014 · strength 0.03
  23. Andrea Tannapfel · 1 shared paper, 2014 · strength 0.03
  24. Darwin Lewis Conwell · 1 shared paper, 2014 · strength 0.03
  25. Anna Wiechowska–Kozłowska · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.